CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Metabolic analyses on both stem cell-enriched (CD34+ and CD34+CD38-) and differentiated (CD34-) cells derived from individuals with CML indicate that primitive CML cells rely on upregulated oxidative metabolism for their survival [178].